CORC

在结果中检索

CORC

浏览/检索结果: 共25条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced Non-Small Cell Lung Cancer: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文
Journal of Thoracic Oncology, 2019
作者:  Yi-Long Wu;  Shun Lu;  Ying Cheng;  Caicun Zhou;  Jie Wang
收藏  |  浏览/下载：15/0  |  提交时间：2019/02/25
Leptomeningeal metastasis after effective first-generation EGFR TKI treatment of advanced non-small cell lung cancer 期刊论文
Lung Cancer, 2019, 卷号: Vol.127, 页码: 1-5
作者:  Ya-Lan Wu;  Qian Zhao;  Lei Deng;  Yan Zhang;  Xiao-Juan Zhou
收藏  |  浏览/下载：19/0  |  提交时间：2019/02/25
Progression of central nervous system metastases in advanced non-small cell lung cancer patients effectively treated with first-generation EGFR-TKI 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2018, 卷号: Vol.13 No.4, 页码: S109-S110
作者:  Yu, M;  Zhao, Q;  Li, Y;  Zhang, S;  Zhou, X
收藏  |  浏览/下载：2/0  |  提交时间：2019/02/25
Randomized, double-blind, placebo-controlled, multicenter Phase II study of fruquintinib after two prior chemotherapy regimens in Chinese patients with advanced nonsquamous non-small-cell lung cancer 期刊论文
Journal of Clinical Oncology, 2018, 卷号: Vol.36 No.12, 页码: 1207-1217
作者:  Lu, S.;  Chang, J.;  Liu, X.;  Shi, J.;  Lu, Y.
收藏  |  浏览/下载：3/0  |  提交时间：2019/02/25
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial. 期刊论文
OncoTargets and therapy, 2018, 卷号: Vol.11, 页码: 8575-8587
作者:  Wu Yi-Long;  Xu Chong-Rui;  Hu Cheng-Ping;  Feng Jifeng;  Lu Shun
收藏  |  浏览/下载：11/0  |  提交时间：2019/02/25
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: A multicentre, randomised phase II trial 期刊论文
British Journal of Cancer, 2018, 卷号: Vol.118 No.5, 页码: 654-661
作者:  Han, B.;  Li, K.;  Zhao, Y.;  Li, B.;  Cheng, Y.
收藏  |  浏览/下载：2/0  |  提交时间：2019/02/25
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2018, 卷号: Vol.13 No.10, 页码: 1539-1548
作者:  Wu, Yi-Long;  Lu, Shun;  Lu, You;  Zhou, Jianying;  Shi, Yuan-kai
收藏  |  浏览/下载：7/0  |  提交时间：2019/02/25
Anlotinib for Refractory Advanced Non-Small Cell Lung Cancer in China. 期刊论文
JAMA oncology, 2018
作者:  Chen Xin-Zu
收藏  |  浏览/下载：1/0  |  提交时间：2019/02/25
512P Osimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS study 期刊论文
Annals of Oncology, 2018, 卷号: Vol.29 Suppl 9
作者:  Q Zhou;  H Zhang;  L Jiang;  Y Shi;  Y Chen
收藏  |  浏览/下载：2/0  |  提交时间：2019/02/25
545TiP Establishment of a prospective multicenter cohort for advanced non-small cell lung cancer in China 期刊论文
Annals of Oncology, 2018, 卷号: Vol.29 Suppl 9
作者:  Y Xu;  L Zhang;  J Fang;  Z Wang;  J li
收藏  |  浏览/下载：3/0  |  提交时间：2019/02/25

©版权所有 ©2017 CSpace - Powered by CSpace